US Stock MarketDetailed Quotes

EYESW Second Sight Medical Products Inc C/Wts 14/03/2024(To Pur Com) R/S

Watchlist
  • 0.0000
  • 0.00000.00%
Close Aug 23 09:30 ET
0Market Cap0.00P/E (TTM)

About Second Sight Medical Products Inc C/Wts 14/03/2024(To Pur Com) R/S Company

Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.

Company Profile

SymbolEYESW
Company NameSecond Sight Medical Products Inc C/Wts 14/03/2024(To Pur Com) R/S
CEOMr. Scott Dunbar
MarketNASDAQ
Employees15

Company Executives

  • Name
  • Position
  • Salary
  • Scott Dunbar
  • Acting Chief Executive Officer
  • --
  • Edward (Ted) Randolph
  • Chief Operating Officer
  • --
  • Edward Sedo
  • Controller, Principal Accounting and Acting Financial Officer
  • --
  • Jessy Dana Dorn
  • Vice President of Clinical and Scientific Affairs
  • --
  • Gregg Williams
  • Chairman of the Board
  • --
  • Jonathan Will Mcguire
  • Director
  • --
  • Dr. Dean Baker
  • Independent Director
  • --
  • Matthew J. Pfeffer
  • Independent Director
  • --
  • Aaron Mendelsohn
  • Independent Director
  • --
  • Alexandra Larson
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg